US Patent Issued to Wuxi Biocity Biopharmaceuticals on May 13 for "Crystal form of pyrimidine sulfonamide compound and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,192, issued on May 13, was assigned to Wuxi Biocity Biopharmaceuticals Co. Ltd. (Jiangsu, China).

"Crystal form of pyrimidine sulfonamide compound and preparation method therefor" was invented by Junmiao Li (Shanghai), Maoyi Lei (Shanghai) and Yunfu Luo (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a Crystal Form (I) of a pyrimidine sulfonamide compound and a preparation method therefor. The present disclosure relates to an application thereof in the preparation of a medicament for treating diseases related to ETA receptor antagonists."

The patent was filed on May 22, 2020, under Application No. 17/595,651.

*For further in...